
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gγ 10 CRISPR Activation Plasmid (m) | sc-420613-ACT | 20 µg | $397.00 | |||
Gγ 10 CRISPR Activation Plasmid (m2) | sc-420613-ACT-2 | 20 µg | $397.00 |
Gng10 encodes the mouse G protein gamma 10 (Gγ10) subunit, a core component of heterotrimeric G proteins that couple activated GPCRs to downstream effectors. By partnering with specific Gα and Gβ subunits, Gγ10 helps control membrane localization and signaling output that can influence adenylyl cyclase activity, phospholipase C signaling, ion channel modulation, and downstream MAPK and PI3K-related responses. These pathways regulate cell communication, secretion, motility, and stimulus-dependent transcriptional programs across many tissues. Altered GPCR–G protein signaling dynamics are broadly relevant to studies of neural function, immune signaling, and cancer-associated signaling rewiring, making Gng10 useful for pathway perturbation experiments in mouse model systems.
Gγ 10 CRISPR Activation Plasmid (m) provides a targeted, non-destructive approach to upregulating endogenous Gng10 expression without altering the underlying DNA sequence.
Gγ 10 CRISPR Activation Plasmid (m) is a three-plasmid synergistic activation mediator (SAM) system engineered for highly efficient, site-specific transcriptional upregulation of the Gng10 locus in human cell lines. The system is built around a catalytically inactive Cas9 (dCas9) carrying two inactivating mutations (D10A and N863A) that eliminate nuclease activity while preserving DNA binding. This dCas9 is fused to VP64, a potent transcriptional activator, and is co-expressed with a blasticidin resistance gene for selection. The second plasmid encodes the MS2-p65-HSF1 fusion protein, a secondary activator complex that works in concert with dCas9-VP64, alongside a hygromycin resistance gene. The third plasmid encodes a target-specific 20 nt sgRNA fused to two MS2 RNA aptamers that recruit the MS2-p65-HSF1 complex to the activation site, accompanied by a puromycin resistance gene. The three plasmids are delivered at a 1:1:1 mass ratio for balanced expression of all system components.
Once assembled at the target locus, the SAM complex binds within approximately 200 bp upstream of the Gng10 transcriptional start site, where VP64, p65, and HSF1 act in concert to recruit transcriptional machinery and drive upregulation of endogenous Gγ 10 expression. Unlike nuclease-active Cas9, dCas9 does not introduce double-strand breaks or modify the genomic sequence, preserving the native Gng10 locus and enabling the study of Gγ 10-dependent transcriptional responses at the endogenous locus, making it a valuable tool for functional studies, target gene identification, and the modeling of Gγ 10 pathway restoration in tumor cells with silenced or reduced Gng10 expression.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.